Hormone replacement therapy associated with improved oxygenation in women with IPF

M. Han, K. Flaherty, G. Toews, R. Edwards, K. Anstrom, F. Martinez (Ann Arbor, Raleigh, United States Of America)

Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Session: Different patterns of diffuse parenchymal lung disease
Session type: Thematic Poster Session
Number: 822
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Han, K. Flaherty, G. Toews, R. Edwards, K. Anstrom, F. Martinez (Ann Arbor, Raleigh, United States Of America). Hormone replacement therapy associated with improved oxygenation in women with IPF. Eur Respir J 2010; 36: Suppl. 54, 822

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effects of hormone replacement therapy on pulmonary function in postmenopausal women
Source: Eur Respir J 2004; 24: Suppl. 48, 574s
Year: 2004

Late-breaking abstract: Postmenopausal hormone replacement therapy is associated with increased risk of asthma hospitalization
Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics
Year: 2011


Hormone replacement therapy may preserve lung function during reproductive aging
Source: International Congress 2017 – Factors associated with lung function development
Year: 2017



Women receiving hormone replacement therapy are at high risk of developing asthma
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020


Nicotine replacement therapy in ICU patients
Source: Annual Congress 2012 - Treatment of tobacco dependence as a treatment of lung diseases
Year: 2012


The effects of hormone therapy on pulmonary function tests in postmenopausal women
Source: Eur Respir J 2004; 24: Suppl. 48, 573s
Year: 2004

Pulmonary function test changes after cessation of inhaled corticosteroid therapy in asthma patients
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012


Characteristics of glucose metabolism in patients receiving glucocorticoid therapy for interstitial lung disease.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017

Successful pregnancy outcome in patients with pulmonary arterial hypertension receiving prostayclin therapy
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004


Survival in COPD patients under long-term oxygen therapy
Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Year: 2019

Using hormone replacement therapy in perimenopausal women with bronchial asthma (BA)
Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma
Year: 2007


Does thyroxin replacement therapy improve dyspnea and diaphragmatic thickness in hypothyroid patients?
Source: Eur Respir J 2006; 28: Suppl. 50, 655s
Year: 2006

Osteoporosis risk associated with chronic corticoid inhalation therapy in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Combined therapy of severe osteoporosis for patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 47s
Year: 2001

Compliance with Adaptive Servo-Ventilation therapy in HF patients with SDB
Source: 5th Sleep and Breathing Conference
Year: 2019

Spirometric abnormalities in patients with fabry disease and effect of substitutive therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 54s
Year: 2004

The effect of androgen replacement treatment on pulmonary functions in male patients with hypogonadism
Source: Eur Respir J 2006; 28: Suppl. 50, 862s
Year: 2006

Long-term oxygen therapy: compliance of patients
Source: Eur Respir J 2001; 18: Suppl. 33, 390s
Year: 2001

Combination therapy of inhaled corticosteroids and long-acting beta2-agonists may be associated with risk reduction of lung cancer in COPD patients who quit smoking
Source: Eur Respir J 2006; 28: Suppl. 50, 454s
Year: 2006

Sex differences in COPD patients users of long-term oxygen therapy
Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients
Year: 2018